Pfizer ( PFE ) recently entered into two deals. While one deal was signed with biopharma company Halozyme Therapeutics, Inc. ( HALO ), the second deal was signed with clinical
The market’s focus in this holiday-shortened week will remain on the unresolved ‘Fiscal Cliff’ situation, but we do have some housing-related data on tap this week, starting with the October
We have upgraded our long-term recommendation on Equifax Inc. ( EFX ) to Outperform from Neutral based on the company’s upbeat third quarter 2012 results and market share gains in its